FAP and cancer: FAP overexpression leads to a higher risk of tumor invasion, lymph node metastasis and to decreased overall survival (OS) [2] and has been shown to be expressed in various cancers including prostate cancer, as well as chronic inflammatory diseases with fibrotic changes [3].